Case Study - Moderna uses the right dose of data to boost discovery

Cambridge, MA based Moderna believes that messenger RNA, or mRNA, is the “software of life.” Since being founded in 2010, the company has worked to pioneer a new class of medicines based on their extensive research into mRNA.

In a highly regulated industry, Moderna knows the critical importance data plays in key processes for the creation, approval, and distribution of vaccines and therapeutics. When the COVID-19 pandemic started in 2020, the pressure to find a fast, effective, and safe vaccine became a global priority.

As the need for accurate, auditable, and actionable insights has become greater, Moderna has leveraged its modern, multicloud data stack to prioritize the job at hand.

Key Takeaways

  • Leverages a multicloud data strategy to use and integrate the best tools for the job at hand
  • Integrates internal and external data sets for a more complete view of clinical trials
  • Increases diversity in clinical trials to improve representation
  • Reduces the time scientists spend on manual data manipulation to increase research time and collaboration
  • Optimizes shipments to reduce costs and meet budget goals
Previous
Moderna favorise les découvertes en utilisant la dose de données adéquate
Moderna favorise les découvertes en utilisant la dose de données adéquate

Dans ce secteur très réglementé, Moderna est consciente du rôle essentiel que jouent les données dans les p...

Next
Looker & SpringML Deliver a System of Intelligence
Looker & SpringML Deliver a System of Intelligence

SpringML works with Looker as the visualization tool of choice to build AI-powered analytics that can scale...

×

Hello! Tell us a little about yourself...

First name
Last name
Phone Number
Company
Number of Employees
By registering, you have read and agree to the Terms of Use and Privacy Policy.
Thank you!
Error - something went wrong!